TM4SF1 and hepatocellular carcinoma: After verifying the promoting effect of TM4SF1 on the cancer stemness of HCC, we speculated based on the close relationship between cancer stemness and tumor drug resistance, that TM4SF1 could enhance the Lenvatinib resistance in HCC cells by promoting the cancer stemness in HCC.